You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
九強生物(300406.SZ):新冠病毒抗原檢測試劑盒獲得歐盟CE准入資格
格隆匯 04-06 21:27

格隆匯4月6日丨 九強生物(300406.SZ)公佈,公司的新型冠狀病毒(2019-nCOV)抗原檢測試劑盒(乳膠法)產品於近日取得歐盟CE准入資格。

新冠病毒檢測是疫情防控的重要手段。公司此次完成新型冠狀病毒檢測產品為抗原檢測試劑(如上述表格所示)。該試劑基於雙抗體夾心法原理,利用乳膠免疫層析技術,定性檢測人鼻拭子中的新型冠狀病毒核衣殼蛋白抗原(N抗原)。新冠抗原自測產品無需檢測設備,具有易於操作、快速出結果的特點,方便個人及家庭進行新冠病毒的快速檢測,可較好地滿足各國疫情居家檢測防控需求。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account